Translating diagnostics and drug delivery technologies to low-resource settings.

Science translational medicine 2022
Open on PubMed

Diagnostics and drug delivery technologies engineered for low-resource settings aim to meet their technical design specifications using strategies that are compatible with limited equipment, infrastructure, and operator training. Despite many preclinical successes, very few of these devices have been translated to the clinic. Here, we identify factors that contribute to the clinical success of diagnostics and drug delivery systems for low-resource settings, including the need to engage key stakeholders at an early stage, and provide recommendations for the clinical translation of future medical technologies.

7 Figures Extracted
Figure 1
Figure 1 PMC
Color intensity correlates to weight of concern in development. From top to bottom; Rapid Diagnostic Tests (RDTs) are cost-effective and have minimal ...
Figure 1
Figure 1 PMC
Barriers to success in LMICs.
Figure 2
Figure 2 PMC
(A) Photographs of the POCT for sickle cell disease based on aqueous multiphase systems (SCD-AMPS). Left: blood wicks into the top of a capillary cont...
Figure 2
Figure 2 PMC
Diagnostic prototype devices tested in LMIC settings.
Figure 3
Figure 3 PMC
(A-D) An intravaginal ring with two polymer phases allows different release rates for LNG (a contraceptive) and TFV (an antiretroviral). (A) Schematic...
Figure 3
Figure 3 PMC
Drug delivery techniques.
Figure 4
Figure 4 PMC
Timeline of MenAfriVac development.